| abstract |
The present invention concerns a compound having the following formula (I): wherein: —A is in particular —N(R′ a )—C(═O)—R, R′ a being H or a (C 1 -C 6 )alkyl group, and R being preferably a group having the following formula (II): —X is in particular chosen from the group consisting of: —SO 2 —N(R′ b )—, R′ b being H or a (C 1 -C 6 )alkyl group, —N(R″ b )—SO 2 —, R″b being H or a (C 1 -C 6 )alkyl group, —CO—NH—, and —NH—CO—, for use for the treatment of pathologies characterized by bronchoconstriction, such as asthma. |